journal cover

Anticonvulsant add-on therapy with Eslicarbazepine acetate : Results of the EPOS-study in adults in Germany

Der Nervenarzt

Aug 24, 2016

F-P LoschE Kockelmann

Abstract

Due to inadequate seizure control achieved with antiepileptic drug (AED) monotherapy and the considerable side effects at high required doses, patients with partial-onset seizures (POS) often require AED combination therapy. Eslicarbazepine acetate (ESL) is licensed as an add-on therapy...read more

Mentioned in this Paper

Study
Anticonvulsants
Combination Drug Therapy
Automated External Defibrillators
Reinforcing Factors
Open Label Study
Orthostasis
Single Seizure
Adverse Event
Site
7
Paper Details
References
  • References15
  • Citations2
12

Anticonvulsant add-on therapy with Eslicarbazepine acetate : Results of the EPOS-study in adults in Germany

Der Nervenarzt

Aug 24, 2016

F-P LoschE Kockelmann

PMID: 27550387

DOI: 10.1007/s00115-016-0199-5

Abstract

Due to inadequate seizure control achieved with antiepileptic drug (AED) monotherapy and the considerable side effects at high required doses, patients with partial-onset seizures (POS) often require AED combination therapy. Eslicarbazepine acetate (ESL) is licensed as an add-on therapy...read more

Mentioned in this Paper

Study
Anticonvulsants
Combination Drug Therapy
Automated External Defibrillators
Reinforcing Factors
Open Label Study
Orthostasis
Single Seizure
Adverse Event
Site
7

Related Papers

Paper Details
References
  • References15
  • Citations2
12
/papers/anticonvulsant-add-on-therapy-with/27550387